We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $295M
1-Year Est. Return 82.72%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+82.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.8M
AUM Growth
-$1.43M
Cap. Flow
-$6.09M
Cap. Flow %
-12.75%
Top 10 Hldgs %
68.46%
Holding
31
New
1
Increased
1
Reduced
18
Closed
9

Top Buys

Rank Stock Value
1
VST icon
Vistra
VST
+$2.93M
2
NEM icon
Newmont
NEM
+$752K

Top Sells

Rank Stock Value
1
HES
Hess
HES
+$931K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$868K
3
AAPL icon
Apple
AAPL
+$868K
4
CI icon
Cigna
CI
+$802K
5
QCOM icon
Qualcomm
QCOM
+$695K

Sector Composition

Rank Sector Weight
1 Healthcare 21.76%
2 Technology 15.94%
3 Materials 15.16%
4 Communication Services 11.71%
5 Energy 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOS icon
1
The Mosaic Company
MOS
$8.22B
$6.25M 13.08%
197,810
-13,587
-6% -$401K
HES
2
DELISTED
Hess
HES
$3.52M 7.36%
49,750
-14,560
-23% -$931K
CVS icon
3
CVS Health
CVS
$124B
$3.42M 7.16%
45,500
-1,885
-4% -$137K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.14T
$3.3M 6.9%
32,000
-8,800
-22% -$868K
CI icon
5
Cigna
CI
$74.7B
$3.08M 6.45%
12,750
-3,600
-22% -$802K
AAPL icon
6
Apple
AAPL
$4.67T
$2.93M 6.13%
24,000
-6,760
-22% -$868K
IP icon
7
International Paper
IP
$19.7B
$2.76M 5.77%
53,856
-9,423
-15% -$459K
VST icon
8
Vistra
VST
$50.1B
$2.6M 5.44%
+147,250
New +$2.93M
MSFT icon
9
Microsoft
MSFT
$3.71T
$2.57M 5.37%
10,895
-1,609
-13% -$373K
CMCSA icon
10
Comcast
CMCSA
$94B
$2.3M 4.81%
42,500
-6,500
-13% -$343K
BG icon
11
Bunge Global
BG
$22.8B
$2.3M 4.81%
29,000
-6,300
-18% -$468K
C icon
12
Citigroup
C
$231B
$2.15M 4.5%
29,575
-4,725
-14% -$315K
QCOM icon
13
Qualcomm
QCOM
$180B
$2.12M 4.44%
16,000
-4,815
-23% -$695K
ABBV icon
14
AbbVie
ABBV
$453B
$2.01M 4.2%
18,550
-4,162
-18% -$445K
LHX icon
15
L3Harris
LHX
$47.8B
$1.86M 3.89%
9,190
-1,530
-14% -$287K
MDT icon
16
Medtronic
MDT
$120B
$1.61M 3.38%
13,600
– –
NEM icon
17
Newmont
NEM
$135B
$994K 2.08%
16,500
+12,564
+319% +$752K
GDX icon
18
VanEck Gold Miners ETF
GDX
$30.7B
$926K 1.94%
28,500
-12,195
-30% -$415K
WMT icon
19
Walmart Inc
WMT
$850B
$306K 0.64%
6,750
– –
BRK.B icon
20
Berkshire Hathaway Class B
BRK.B
$1.08T
$293K 0.61%
1,150
-900
-44% -$219K
UNH icon
21
UnitedHealth
UNH
$356B
$279K 0.58%
750
-250
-25% -$86.6K
JPM icon
22
JPMorgan Chase
JPM
$953B
$228K 0.48%
1,500
-100
-6% -$14.4K
CTVA icon
23
Corteva
CTVA
$58.6B
– –
-6,550
Closed -$254K
DAL icon
24
Delta Air Lines
DAL
$52.7B
– –
-5,400
Closed -$217K
DOW icon
25
Dow Inc
DOW
$21.3B
– –
-2,875
Closed -$160K
1
2

Similar funds

STT
Singapore Technologies Telemedia Singapore $295M AUM 1.77% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
IRP
Investment Research Partners Lemont, Pennsylvania $295M AUM 34.97% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $295M AUM 95.45% 1-Year Est. Return
CG
Clarus Group Houston, Texas $295M AUM 20.77% 1-Year Est. Return
UHC
Union Heritage Capital Bloomfield Hills, Michigan $295M AUM 28.37% 1-Year Est. Return
PI
PJT Investments Toronto $296M AUM 9.02% 1-Year Est. Return
CNBT
Cornerstone National Bank & Trust Palatine, Illinois $296M AUM 12.13% 1-Year Est. Return

Colrain Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Colrain Capital held 31 positions worth $47.8M, down 2.9% from $49.2M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Colrain Capital withdrew a net $6.09M in Q1 2021, closing 9 positions and reducing 18 holdings. Its most notable exit was Pfizer, an estimated $574K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Materials.

Against the trend, Colrain Capital opened a new position in Vistra worth $2.6M.

  • Colrain Capital's largest Q1 2021 buy was Vistra: 147,250 shares worth $2.6M.
  • Colrain Capital added most to Newmont in Q1 2021, an estimated $752K increase.
  • Colrain Capital's biggest Q1 2021 reduction was Hess, cutting an estimated $931K.
  • Colrain Capital fully exited Pfizer in Q1 2021, selling an estimated $574K.
  • Colrain Capital's ten largest holdings make up 68% of its $47.8M portfolio in Q1 2021.
  • Colrain Capital opened 1 new position and closed 9 in Q1 2021.
  • Colrain Capital's portfolio value fell 2.9% quarter-over-quarter to $47.8M.

Based on Colrain Capital's 13F filing for Q1 2021, filed 30 Apr 2021.